文献速递肝胆胰外科围术期管理与 ERAS

加速肝再生的新技术:大鼠实验研究

A new technique for accelerated liver regeneration: An experimental study in rats.
PubMed 文献 · Surgery · 2017-04-10

该研究在大鼠中比较门静脉结扎、ALPPS 及射频消融相关改良术式对剩余肝再生的影响,共 152 只大鼠随机分组,于术后第 2、4 天评估。结果显示各干预组肝再生率均高于假手术组,射频消融去门脉化肝组织可获得与 ALPPS 相当的剩余肝生长。

要点

  • 各干预组肝再生率均较假手术组持续升高
  • 射频消融去门脉化肝组织可达到与 ALPPS 相当的剩余肝生长
  • 该术式在人类中首步可经皮完成

核心结论

  • ALPPS 后的额外肝再生可能由实质损伤及生长刺激因子释放介导,上调细胞再生相关基因并下调细胞稳态相关基因。
  • 射频消融处理去门脉化肝组织可获得与 ALPPS 相当的剩余肝生长,该操作在人类中首步可经皮完成。

研究设计与样本

  • 大鼠实验研究,共 152 只大鼠随机分为 7 组:假手术、门静脉结扎、门静脉结扎/手术分隔(ALPPS)、门静脉结扎/射频消融针分隔肝脏、门静脉结扎/去门脉化肝射频消融、门静脉结扎/剩余肝射频消融及对照组。
  • 于术后第 2 天和第 4 天评估体重、肝脏参数、肝再生率、促炎细胞因子、肝细胞增殖及基因表达。

主要发现

  • 与假手术组相比,所有干预组肝再生率均稳步升高(P < .001)。
  • 术后第 2 天,门静脉结扎/去门脉化肝射频消融组肝再生率显著高于门静脉结扎组(P = .039)。
  • 术后第 4 天,门静脉结扎组与 ALPPS 组(P = .015)、门静脉结扎/射频消融针分隔肝脏组(P = .010)、门静脉结扎/去门脉化肝射频消融组(P = .046)之间差异显著。
  • 肝细胞增殖在所有时间点均显著高于假手术组;术后第 4 天,第 3、4、5、6 组增殖显著高于门静脉结扎组。
  • 基因分析显示各干预组细胞增殖相关基因上调、细胞稳态相关基因下调;干预组间基因表达几乎相同,生化标志物和促炎细胞因子组间相当。

临床怎么用

  • 射频消融去门脉化肝组织可作为加速剩余肝生长的潜在替代策略,且人类首步可经皮实施。
  • 机制上可能通过实质损伤释放生长刺激因子,为 ALPPS 的再生机制提供解释。

局限性

  • 研究为大鼠实验,结果向人类临床转化需进一步验证。
  • 仅评估术后第 2 天和第 4 天两个时间点,缺乏更长期再生与安全性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is used to accelerate growth of the future liver remnant. We investigated alternative methods for increasing the future liver remnant. METHODS: A total of 152 rats were randomized as follows: (1) sham; (2) portal vein ligation; (3) portal vein ligation/surgical split (ALPPS); (4) portal vein ligation/split of the liver with a radiofrequency ablation needle; (5) portal vein ligation/radiofrequency ablation of the deportalized liver (portal vein ligation/radiofrequency ablation necrosis in the deportalized liver); (6) portal vein ligation/radiofrequency ablation of the future liver remnant (portal vein ligation/radiofrequency ablation-future liver remnant); and (7) controls. Animals were evaluated on postoperative days 2 and 4. Bodyweight, liver parameters, hepatic regeneration rate, proinflammatory cytokines, hepatocyte proliferation, and gene expression were measured. RESULTS: Hepatic regeneration rate indicated a steady increase in all intervention groups compared with sham rats (P < .001). At postoperative day 2, the hepatic regeneration rate was significantly higher in the portal vein ligation/radiofrequency ablation necrosis in the deportalized liver group than in the portal vein ligation group (P = .039). On postoperative day 4, we found significant differences between the portal vein ligation group and the ALPPS (P = .015), portal vein ligation/split of the liver with a radiofrequency ablation needle (P = .010), and portal vein ligation/radiofrequency ablation necrosis in the deportalized liver (P = .046) groups. Hepatocyte proliferation was significantly higher at all times compared with sham rats. On postoperative day 4, we found a significantly higher proliferation in groups 3, 4, 5, and 6 compared to portal vein ligation. Gene analysis revealed upregulation of genes involved in cellular proliferation and downregulation of genes involved in cellular homeostasis in all intervention groups. Between the intervention groups, gene expression was nearly identical. Biochemical markers and proinflammatory cytokines were comparable between groups. CONCLUSION: The surplus liver regeneration after ALPPS is probably mediated through parenchymal damage and subsequent release of growth stimulators, which again upregulates genes involved in cellular regeneration and downregulates genes involved in cellular homeostasis. We also demonstrate that growth of the future liver remnant, comparable to that seen after ALPPS, could be achieved by radiofrequency ablation treatment of the deportalized liver, that is, a procedure in which the initial step in humans can be performed percutaneously.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Andersen KJ, Knudsen AR, Jepsen BN, et al. A new technique for accelerated liver regeneration: An experimental study in rats. Surgery. 2017. PMID: 28408101. doi:10.1016/j.surg.2017.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。